LCL161
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LCL161, covering 2012-08-03 to 2023-06-06. Get the full timeline:
Most recent: Clinical Trial Update: LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis [Phase 2]